Lancet Oncol:儿童感染肠道病毒(手足口病等)可以减少白血病风险?!

2015-10-27 Seven L 译 MedSci原创

研究者进行了一项研究,探究儿童肠道病毒感染后发生白血病的风险。该研究对NHIRD数据进行了全国性的回顾性队列研究。纳入了<18岁感染肠病毒的儿童,根据性别、年龄、城市化水平、父母职业、肠道病毒感染年份等按1:1对其匹配非肠病毒感染儿童。研究者仅仅纳入了含有完整信息、至少去过3次诊所诊断为肠病毒感染的儿童。按照第一次诊断为肠病毒感染时间作为起始随访时间。对所有研究对象进行随访,直到发生白血病或失访

c研究者进行了一项研究,探究儿童肠道病毒感染后发生白血病的风险。

该研究对NHIRD数据进行了全国性的回顾性队列研究。纳入了<18岁感染肠病毒的儿童,根据性别、年龄、城市化水平、父母职业、肠道病毒感染年份等按1:1对其匹配非肠病毒感染儿童。研究者仅仅纳入了含有完整信息、至少去过3次诊所诊断为肠病毒感染的儿童。按照第一次诊断为肠病毒感染时间作为起始随访时间。对所有研究对象进行随访,直到发生白血病或失访或退出或直到实验结束。该研究的初始结局指标为随访期间白血病的发生情况。

该研究在2000-1-1至2007-12-31日从NHIRD数据里筛查了3 054 336名小于18岁儿童。纳入282 360名肠病毒感染儿童和 282 355 名对照组儿童。肠病毒感染组白血病发生率为 3.26/100 000人年,对照组为5.84/100 000人-年。肠病毒组白血病发生风险低于对照组 (aSHR0.44, 95% CI 0.31-0.60; p<0.0001)。儿童感染肠病毒可以减少淋巴细胞性白血病风险 (aSHR 0.44, 0.30-0.65; p<0.0001),减少急性髓性白血病风险 (aSHR 0.40, 0.17-0.97; p=0.04)。在肠病毒感染相关疾病里,疱疹性咽峡炎和手足口病是减少白血病风险的主要疾病。

研究结果表明,儿童肠道病毒感染可以减少白血病风险。该结果支持了白血病病因:Greaves' 延迟感染假说。

原始出处:

Lin JN, Lin CL, Lin MC,et al.Risk of leukaemia in children infected with enterovirus: a nationwide, retrospective, population-based, Taiwanese-registry, cohort study.Lancet Oncol. 2015 Oct;16(13):1335-43.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2016-07-06 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2016-06-08 IIIi

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2016-09-21 howi
  4. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2016-07-31 lingqf
  5. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-11-05 田田1746

    呵呵

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    收藏

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-30 三三五五

    这不能说明什么问题吧

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-28 梦想天空

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1864724, encodeId=e99f1864e24e6, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Wed Jul 06 19:44:00 CST 2016, time=2016-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89034, encodeId=e5a38903489, content=这, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8aa11659262, createdName=IIIi, createdTime=Wed Jun 08 12:45:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828278, encodeId=45b918282e881, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Sep 21 01:44:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678321, encodeId=a4a316e832142, content=<a href='/topic/show?id=256154569b3' target=_blank style='color:#2F92EE;'>#手足口#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54569, encryptionId=256154569b3, topicName=手足口)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbc627685059, createdName=lingqf, createdTime=Sun Jul 31 12:44:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42572, encodeId=cb11425e286, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Thu Nov 05 06:49:00 CST 2015, time=2015-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42236, encodeId=ba084223642, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:18:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42015, encodeId=95534201577, content=这不能说明什么问题吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Fri Oct 30 22:00:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454610, encodeId=05721454610c3, content=<a href='/topic/show?id=2bd981e071f' target=_blank style='color:#2F92EE;'>#肠道病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81707, encryptionId=2bd981e071f, topicName=肠道病毒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2a9a5579963, createdName=liye789132253, createdTime=Thu Oct 29 06:44:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41684, encodeId=65b941684c7, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Wed Oct 28 09:01:00 CST 2015, time=2015-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41648, encodeId=125941648bb, content=有关联,是不是因果关系看看原文怎么说, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191d1636362, createdName=wodexinxi, createdTime=Wed Oct 28 06:12:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-28 wodexinxi

    有关联,是不是因果关系看看原文怎么说

    0

相关资讯

砒霜治疗白血病奠基人张亭栋获求是100万大奖 一生默默无闻

今天下午3点17分,香港求是科技基金会宣布,将金额为100万元的“求是杰出科学家奖”授予一位默默无闻的医生张亭栋教授,奖励其在使用砒霜(三氧化二砷,ATO)治疗白血病上所作出的奠基性贡献。 张亭栋现年82岁,是哈尔滨医科大学附属第一医院(下称“哈医大一附院”)的教授,曾任该院中医教研室主任。因为身体状况不佳,张亭栋没有亲自出席今天在中国科技大学举行的颁奖典礼,其奖项由其两位同事代领。

Nature:糖尿病药物吡格列酮或可用于治疗白血病

药物研发中总有各种千奇百怪的“意外”。如果不是弗莱明在培养基上多看了一眼,或许青霉素的发现还会推迟许多年。而这些美丽的“意外”往往会进一步推动人类的进步。最近,一个国际研究团队就发现以往用于治疗糖尿病的药物——吡格列酮或许能够帮助人类更好的对抗白血病。 慢性粒细胞白血病(CML)是一种罕见疾病,每年英国境内有600人被诊断患有这种疾病。尽管市面上有数种畅销疗法,但并不适用于所有患者。此外,

Nature:测序分析发现驱动白血病发生发展和进化的基因突变

近日,来自美国和德国的科学家们在国际学术期刊Nature上发表了一项最新研究进展,他们通过对慢性淋巴细胞白血病病人样本进行全外显子测序分析,发现了一些可能发生反复突变的癌症驱动基因,这对于了解肿瘤形成过程以及癌细胞进化过程具有重要意义。   究竟哪个基因突变会驱动肿瘤形成以及在疾病发展和治疗过程中癌细胞如何进化是癌症生物学研究中的两个关键问题,而肿瘤学家们也在寻找这两个问题的答案上孜

NEJM:维罗非尼治疗复发或难治性毛细胞白血病效果

Figure 1. Extent and Duration of Response in the 25 Patients Who Had a Response to Vemurafenib in the Italian Trial.BRAF V600E是毛细胞白血病患者潜在的基因损害。本项研究旨在对接受嘌呤类似物治疗后的复发性或难治性患者评估口服BRAF抑制剂维罗非尼治疗毛细胞白血病的安全性以及活

Sci Transl Med:CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著

难治性或多次复发的慢性淋巴细胞白血病(CLL)的患者预后较差。靶向CD19的嵌合抗原受体(CAR)T细胞对B细胞恶性肿瘤的持续缓解,具有提高常规疗法低缓解率的潜力。我们曾经报道过3例难治性CLL治疗的初步研究结果。现在我们报道使用CAR-T细胞治疗的14例复发性难治性CLL患者的初步试验中成熟的研究结果。用慢病毒载体导入CD19 CAR的自体T细胞(CTL019),输注给复发/难治性CLL患者

Nature:常用糖尿病药物的抗癌作用

一项发表在9月2日《自然》(Nature)杂志上的新研究表明,将一些常用糖尿病药物添加到标准治疗中或可帮助消灭某种白血病形式中的耐药癌细胞。研究人员发现同时接受格列酮(glitazone,一类2型糖尿病药物)及标准CML药物伊马替尼治疗(Imatinib)的慢性粒细胞白血病(CML)患者可以在长达近5年的时间内疾病不复发。伊马替尼的商品名为格列卫(Gleevec),在控制慢性粒细胞白血病中有着令人